Fairvalue-Calculator Fairvalue-Calculator
EN DE

Rubicon Organics Inc (ROMJF) Fair Value & Analysis

Healthcare · US · Market cap $21.9M

Price$0.3230
Fair Value$0.3200
Upside-0.9%
Quality95/100
Evidence: Medium Range $0.3200 – $0.3200

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Rubicon Organics Inc (ROMJF) currently trades at $0.3230, while our model-based Fair Value estimate is $0.3200 — implying the stock looks roughly 0.9% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Rubicon Organics Inc., together with its subsidiaries, engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally. The company offers cannabis products in dried flower, pre-rolls, concentrates, gummies, capsules, edibles, vapes, topicals, relief sticks, and oils. It sells its products under the Simply Bare Organic, 1964 Supply Co, Homestead Cannabis Supply, and Wildflower brand names. The company was formerly known as West Coast Land Corporation and changed its name to Rubicon Organics Inc. in May 2018. Rubicon Organics Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Rubicon Organics Inc (ROMJF) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $0.3200 versus a price of $0.3230 — about −1% (overvalued). Model-based estimate, not financial advice.
What is the fair value of ROMJF?
Our 21-model fair value for Rubicon Organics Inc is $0.3200 (as of Jun 24, 2026), built from audited fundamentals. The current price is $0.3230.
What is the quality score of ROMJF?
Rubicon Organics Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.